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a  b  s  t  r  a  c  t
A  55-year-old  woman  was  admitted  with  heart  failure.  On the third  hospital  day,  she suddenly  developed
cerebral  infarction.  The  resting  12-lead  electrocardiography  showed  normal  sinus  rhythm,  and  atrial
ﬁbrillation  or  ﬂutter  were  never  detected  on  electrocardiographic  monitoring  throughout  the  whole
hospital  days.  She  had  no  other  conventional  risk  factor  for cerebral  infarction.  Transthoracic  echo-
cardiography  showed  left ventricular  hypertrophy.  Transesophageal  echocardiogram  revealed  strong
spontaneous  echo  contrast  in  the  left atrium  (LA),  and  the  blood  ﬂow  in  the  left  atrial  appendage  was
extremely  decreased  (22.3  cm/s).  Late  gadolinium  enhancement  in  cardiac  magnetic  resonance  (CMR)
imaging  showed  global  subendocardial  hyperenhancement  of  the  left ventricle  and  both  atria.  Endomy-
ocardial  biopsy  specimen  was  positive  for amyloid  by  Congo  red staining.  Marked  amyloid  inﬁltration  to
both atria  might  cause  atrial  dysfunction  leading  to  thrombus  formation  in the  LA. CMR  is  thought  to be
a useful  noninvasive  tool  to detect  atrial  myopathy  in  cardiac  amyloidosis  patients.
<Learning  objective:  In cardiac  amyloidosis  patients,  late  gadolinium  enhancement  on CMR  in the atria
might  be  an important  sign,  which  would  suggest  atrial  amyloid  deposition  with  impaired  atrial  func-
tion.  CMR  is  thought  to be a useful  noninvasive  tool  to  detect  even  atrial  myopathy  in cardiac  amyloidosis
patients.  Furthermore,  we recommend  to  evaluate  the  atrial  function  using  transesophageal  echocardiog-
raphy in  these  patients.  If impaired  atrial  function  was  detected,  despite  with  or  without  atrial  ﬁbrillation,
they  should  receive  anticoagulation  therapy  for preventing  the  thromboembolic  event.>
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Cardiac amyloidosis is an inﬁltrative heart disease due to amy-
oid deposition. The inﬁltrative process results in ventricular and
trial wall thickening, which often results in heart failure and lethal
rrhythmia [1].  Meanwhile, cerebral embolism associated with car-
iac amyloidosis has rarely been reported and the mechanism is
nknown.
In cardiac amyloidosis, cardiac magnetic resonance (CMR)
maging commonly shows global subendocardial late gadolinium
nhancement (LGE) in the ventricles. These ﬁndings suggest that
MR plays an important role in assessing myocardial amyloid
urden in cardiac amyloidosis [2]. We  report a case of cerebral
mbolism due to atrial myopathy in cardiac amyloidosis diagnosed
y CMR.
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Case report
A 55-year-old woman  presented with dyspnea on exertion.
Clinical examination revealed jugular venous dilatation, gallop of
the third heart sound, hepatomegaly, and marked edema in both
lower extremities. A chest radiograph showed cardiomegaly with
mild pulmonary congestion and bilateral pleural effusions. The
resting 12-lead electrocardiography showed sinus rhythm, low
voltage QRS complexes, lateral T-wave inversion, and poor R-wave
progression in precordial leads (Fig. 1A). Transthoracic echocardi-
ography showed concentric left ventricular hypertrophy with small
cavity (left ventricular diastolic dimension was 42.2 mm), mildly
decreased systolic function (left ventricular ejection fraction was
48.2%), small pericardial effusion, enlargement of both atria, and
moderate mitral regurgitation and moderate tricuspid regurgita-
tion (Fig. 1B). Findings of transmitral Doppler ﬂow were consistent
with restrictive physiology, which comprised shortened decelera-
tion time of the early ﬁlling (E) wave (108 ms) and a low-velocity
of the atrial contraction (A) wave (21.2 cm/s) (Fig. 1C). On the third
hospital day, she suddenly developed transient left hemiparesis.
Diffusion-weighted magnetic resonance imaging (MRI) of the brain
vier Ltd. All rights reserved.
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Fig. 1. Electrocardiography and transthoracic echocardiography. (A) The resting 12-lead electrocardiography showed sinus rhythm, low voltage QRS complexes, lateral T-
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tory of heart disease or sudden death. The clinical details and
histopathological ﬁndings would best ﬁt with the diagnosis of sys-
temic light-chain cardiomyopathy. Her heart failure was  carefully
treated with diuretics and a low dose of angiotensin-converting
Table 1
Patient’s blood biochemical, hematological parameters, and proteinuria.
Value
Complete blood count
Hemoglobin (g/dl) 14.1
Hematocrit (%) 41.2
White blood cell (103 mm−3) 4.59
Mean corpuscular volume (ﬂ) 89.8
Red cell distribution width (%) 10.4
Blood biochemistry
Blood urea nitrogen (mg/dl) 21
Creatinine (mg/dl) 0.6
Alanine aminotransferase (U/l) 25
Aspartate aminotransferase (U/l) 17
Total bilirubin (mg/dl) 0.9
Na (mequiv./l) 136
K  (mequiv./l) 4.6
C-reactive protein (mg/dl) 0.02
Total protein (g/dl) 5.7
Albumin (%) 62.7
˛1 (%) 4.6ave  inversion, and poor R-wave progression in precordial leads. (B) Transthoracic e
ecreased systolic function, small pericardial effusion, and enlargement of both atr
t 1 h after the onset showed no abnormality. But on the next day,
ollow-up MRI  revealed high intensity area compatible with acute
nfarction in the right middle cerebral arterial territories. Magnetic
esonance angiography showed total occlusion of the distal portion
f the right middle cerebral artery (Fig. 2). She had no history of
ypertension or diabetes, and had never smoked nor drunk alcohol.
o arrhythmias, including atrial ﬁbrillation, were detected by elec-
rocardiographic monitoring throughout the whole hospital days.
he had no symptom of palpitation or other evidence of arrhythmia
efore admission. Intima-media thickness of the carotid arteries
as not thickened.
A transesophageal echocardiography showed no thrombus in
he left ventricular cavity, left atrium (LA), or left atrial appendage
LAA). However, there was strong spontaneous echo contrast in
he LA, and the ﬂow velocity in the LAA was extremely decreased
22.3 cm/s) (Fig. 3), which suggested a trial dysfunction. Patent fora-
en  ovale was not detected by contrast echocardiography with
ntravenously administered saline and Valsalva maneuvers. A CMR
tudy with gadolinium contrast was performed in order to fur-
her investigate myocardial characteristics. Global subendocardial
GE was seen in both ventricles, both atria, and in the interatrial
eptum (Fig. 4). Right ventricular endomyocardial biopsy speci-
en  was positive for amyloid by Congo red staining (Fig. 5). The
ndings of biopsy showed extracellular amyloid inﬁltration. Serum
rotein electrophoresis identiﬁed as an IgG, M component with
ambda light-chain restriction on immunoﬁxation. Urine protein
lectrophoresis identiﬁed Bence-Jones protein (Table 1). Bone mar-
ow analysis revealed no signs of myeloma. Although we  did notdiography showed concentric left ventricular hypertrophy with small cavity, mildly
Findings of transmitral Doppler ﬂow were consistent with restrictive physiology.
check genetic testing for transthyretin, there was no family his-˛2 (%) 9.5
ˇ (%) 10.1
  (%) 13.1
Bence-Jones proteinuria Positive
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Fig. 2. Head magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA). On brain diffusion-weighted MRI, there are high intensity area in the cortex of
the  right insular and temporal lobe. MRA  shows total occlusion (arrows) of the right distal portion of the middle cerebral artery, which could be caused by thromboembolism.
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lig. 3. Transesophageal echocardiogram shows left atrium and left atrial appenda
ecreased (22.3 cm/s).nzyme inhibitor. In addition, to prevent recurrence of cere-
ral embolism, she was treated with anticoagulant therapy. Her
eurological condition improved, and she did not have any neuro-
ogical deﬁcits.A). Doppler echocardiogram shows LAA ﬂow. The LAA ﬂow velocity is remarkablyDiscussion
Cardiac amyloidosis describes clinically signiﬁcant involvement
of the heart by amyloid deposition. Cardiac extracellular amyloid
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Fig. 4. Cardiac magnetic resonance imaging. The late gadolinium enhancement images sh
interatrial septum in the short-axis (A and B) and vertical long-axis (C) views.
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rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissocia-ig. 5. Pathological ﬁndings (Congo red staining). Endomyocardial biopsy speci-
en  from right ventricle showed amyloid deposition in interstitial space around
ndividual myocytes (Congo red staining).
nﬁltration occurs in the ventricles, atria, valves, and conduction
ystem, which results in the cardiac disorders comprising heart
ailure, arrhythmia, and conduction block [1].  On the other hand,
erebral embolism related to cardiac amyloidosis is rarely reported.
Atrial ﬁbrillation is one of the most common causes of car-
ioembolic stroke and thrombus is usually detected in LA or LAA.
owever, it has been reported that LA thrombus was detected in
atients with sinus rhythm, when high grade LA spontaneous echo
ontrast or markedly decreased Doppler velocity in the LAA were
een [3].  In patients with cardiac amyloidosis, thrombus forma-
ion in the LA was also reported even during sinus rhythm. These
atients showed impaired atrial function, which might be caused
y amyloid inﬁltration in the atrial wall, when they were evaluated
y echocardiography [4].
[ow global subendocardial hyperenhancement of both ventricles, both atria and the
In  cardiac amyloidosis, the characteristics of the LGE are seen
in global biventricular subendocardium, associated with abnormal
myocardial and blood-pool gadolinium kinetics [2].  These ﬁndings
are thought to be due to the accumulation of abnormal intersti-
tial protein causing enlargement of the extracellular space [5].
Histologically, cardiac amyloidosis is characterized by interstitial
expansion with amyloid protein in both ventricles and atria [2].
In this case, global subendocardial LGE was also found in not
only ventricles but also atria. It is thought that amyloid inﬁltra-
tion occurred in the atria, and then resulted in the intrinsic atrial
dysfunction.
This case has two important messages. Firstly, in cardiac amy-
loidosis patients, LGE on CMR  in the atria might be an important
sign, which would suggest atrial amyloid deposition with impaired
atrial function. Secondly, with or without atrial arrhythmia, we
should evaluate the atrial function using transesophageal echo-
cardiography in these patients. If impaired atrial function was
detected, they should receive anticoagulation therapy for preven-
ting thromboembolic events.
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